Synapse - Find an Expert

33620 Results

A multi-institutional retrospective analysis of T-cell lymphomas with central nervous system relapse

Meeting Abstract

Bhansali, R. S.; Ganesan, N.; Stuver, R. N.; Horwitz, S. M.; Wudhikarn, K.; Hwang, S. R.; Bennani, N.; Chavez, J. C.; Sokol, L.; Saeed, H.; more...
Blood (2021)

Fulltext@MSK | Save

Interim analysis of the randomized phase 1b/3 study evaluating the safety and efficacy of tazemetostat plus lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma

Meeting Abstract

Batlevi, C. L.; Park, S. I.; Nastoupil, L.; Phillips, T.; Amengual, J. E.; Andorsky, D.; Campbell, P.; McKay, P.; Pagel, J. M.; Leonard, J. P.; more...
Blood (2021)

Fulltext@MSK | Save

Subcutaneous epcoritamab in combination with R-CHOP in patients with previously untreated high-risk diffuse large B-cell lymphoma: Preliminary results from a phase 1/2 trial

Meeting Abstract

Belada, D.; Christensen, J. H.; Drott, K.; Snauwaert, S.; Brody, J.; Narkhede, M.; Offner, F.; Elliot, B.; Liu, T.; Stirner, M. C.; more...
Blood (2021)

Fulltext@MSK | Save

A phase 1 study of CFT7455, a novel degrader of IKZF1/3, in multiple myeloma and non-Hodgkin lymphoma

Meeting Abstract

Berdeja, J.; Ailawadhi, S.; Horwitz, S. M.; Matous, J. V.; Mehta-Shah, N.; Martin, T.; Muchtar, E.; Richardson, P. G.; Richard, S.; Bhutani, M.; more...
Blood (2021)

Fulltext@MSK | Save

Subcutaneous (SC) administration of mosunetuzumab with cycle 1 step-up dosing is tolerable and active in patients with relapsed/refractory B-cell non-Hodgkin lymphomas (R/R B-NHL): Initial results from a phase I/II study

Meeting Abstract

Bartlett, N. L.; Giri, P.; Budde, L. E.; Schuster, S. J.; Assouline, S.; Matasar, M. J.; Yoon, S. S.; Canales, M.; Gutierrez, N. C.; Fay, K.; more...
Blood (2021)

Fulltext@MSK | Save

Trial-in-progress: Randomized phase II trial in early relapsing or refractory follicular lymphoma (NCT# 03269669): SWOG S1608

Meeting Abstract

Barr, P. M.; Li, H.; Link, B. K.; Flowers, C. R.; Burack, R.; Schöder, H.; Leblanc, M. L.; Weigert, O.; Herrera, A. F.; Weinstock, D. M.; more...
Blood (2021)

Fulltext@MSK | Save

Rational targets in systemic AL amyloidosis

Meeting Abstract

Bal, S.; Dogan, A.; Hassoun, H.; Mailankody, S.; Giralt, S. A.; Landau, H. J.
Blood (2021)

Fulltext@MSK | Save

Safety and efficacy of FT596, a first-in-class, multi-antigen targeted, off-the-shelf, iPSC-derived CD19 car NK cell therapy in relapsed/refractory B-cell lymphoma

Meeting Abstract

Bachanova, V.; Ghobadi, A.; Patel, K.; Park, J. H.; Flinn, I. W.; Shah, P.; Wong, C.; Bickers, C.; Szabo, P.; Wong, L.; more...
Blood (2021)

Fulltext@MSK | Save

Multicenter analysis of treatment and outcomes for patient with TP53 mutated AML in the era of novel therapies; Significant impact of allogeneic stem cell transplantation on survival